Menu
Request an Appointment

Curriculum Vitae (CV) Continued

< Back to Cardiology

Publications

Journals

  1. Wilson JM, Ferguson JJ: The therapeutic potential of abcirximab (c7E3 Fab) in percutaneous transluminal coronary angioplasty: Implications of the EPIC study. Clin Immunother 1994; 1(1):1-7.
  2. Wilson JM, Silberman H, Ferguson JJ: Abrupt vascular closure. Journal of Invasive Cardiology 1994; 6:306-313.
  3. Wilson JM, Dougherty KG, Ellis KO, Ferguson JJ: Activated clotting times in acute coronary syndromes and percutaneous coronary angioplasty. Cathet Cardiov Diag 1995; 34:1-5.
  4. Wilson JM, Ferguson JJ: Revascularization therapy for coronary artery disease. Coronary artery bypass grafting versus percutaneous transluminal coronary angioplasty. Tex Heart Inst J 1995; 22:145-161.
  5. Ferguson JJ, Barasch E, Wilson JM, et al.: The relation of clinical outcome to dissection and thrombus formation during coronary angioplasty. J Inv Cardiol 1995; 7:2-10.
  6. Ferguson JJ, Dohmen P, Wilson JM, Vaughn WK, Khoshnevis R, Kmonicek P, McKinney AA, Plachetka JR: Results of a national survey on anticoagulation for PTCA. J Invas Cardiol 1995; 7:136-141.
  7. Barasch E, Conger JL, Peters JJ, Nesdahl K, Fenimore JG, Wilson JM, Ferguson JJ: PTCA in angulated segments: Effects of balloon material, balloon length, and inflation sequence on straightening forces in an in-vitro model. Cathet Cardiov Diagn 1996; 39:207-212.
  8. Wilson JM, Kalife G, Rogers M, Strickman N, Massumi AM: An unusual electrocardiographic presentation of right ventricular infarction. THI Journal 1996;4:305-9.
  9. Ferguson JJ, Waly H, Le D, Thomakos N, Wilson JM. The effect of body weight and body surface area connection on the distribution of the ACT response to bolus doses of heparin for PTCA. J Inv Cardiol 1998;10:318-22.
  10. Wilson JM. Reversible congestive heart failure caused by myocardial hibernation. Tex Heart Inst J 1999; 26:19-27.
  11. Wilson JM, Ferguson JJ. Platelet-endothelial interactions in atherothrombotic disease: therapeutic implications. Clin Cardiol 1999; 22:687-98.
  12. Ferguson JJ, Thomakos N, Lau TK, Wilson JM. Overview of oral glycoprotein IIb/IIIa antagonist therapy in vascular disease. J Invasive Cardiol. In Press.
  13. Angelini P, Vaughn WK, Zaqqa M, Wilson JM, Fish RD. Impact of the "stent-when-feasible" policy on in-hospital and 6-month success and complication rates after coronary angioplasty: single-center experience with 17,956 revascularization procedures (1993-1997). Tex Heart Inst J. 2000;27(4):337-45.
  14. Villareal R, Achari A, Wilansky S, Wilson JM. Dynamic left ventricular outflow tract obstruction secondary to myocardial stunning. Mayo Clinic Proceedings 2001;76:79-83.
  15. Villareal RP, Kim P, Ferguson JJ 3rd, Wilson JM. Unstable angina and non-ST-segment elevation myocardial infarction: perspectives on combination therapy. Tex Heart Inst J. 2001;28(4):276-87.
  16. Wilson JM, Villareal RP, Hariharan R, Massumi AG, Muthupillai R, Flamm SD. Magnetic Resonance Imaging of Myocardial Fibrosis in Hypertrophic Cardiomyopathy. Tex Heart Inst J 2002;29:176-80.
  17. Villareal RP, Lee VV, Elayda M, Hall RJ, Wilson JM. Coronary artery bypass surgery versus coronary stenting: risk-adjusted survival rates in 5,619 patients. Tex Heart Inst J 2002;29(1): 3-9.
  18. Villareal RP, Hariharan R, Liu BC, Kar B, Lee VV, Elayda M, Lopez JA, Rasekh A, Wilson JM, Massumi A. Postoperative atrial fibrillation and mortality after coronary artery bypass surgery. : J Am Coll Cardiol. 2004 Mar 3;43(5):742-8.
  19. Nemeth MA, Muthupillai R, Wilson JM, Flamm SD. Cardiac Sarcoidosis Detected by Delayed-Hyperenhancement Magnetic Resonance Imaging. Tex Heart Inst J. 2004; 31(1):99-102.
  20. Muthupillai R, Flamm SD, Wilson JM, Pettigrew RI, Dixon WT. Acute Myocardial Infarction: Tissue Characterization with T1{rho}-weighted MR Imaging--Initial Experience. Radiology. 2004;232:606-10.
  21. Wilson JM. Stents or surgery: the case for stents. Tex Heart Inst J. 2005;32(3):331-8.
  22. Wilson JM, Gilbert J, Harlan M, Bracey A, Allison P, Schooley C, Pinto K. High-dose intravenous dalteparin can be monitored effectively using standard coagulation times.Clin Appl Thromb Hemost. 2005 Apr;11(2):127-38.
  23. Frank CM, Palanichany N, Kar B, Wilson JM, Gregoric ID, Loyalka P, Civitello AB. Use of a percutaneous ventricular assist device for treatment of cardiogenic shock due to critical aortic stenosis. Tex Heart Inst J. 2006;33(4):487-9.
  24. Mitchell J, Hadden TB, Wilson JM, Achari A, Muthuuupillai R, Flamm SD. Clinical Features and Usefulness of Cardiac Magnetic Resonance Imaging in Assessing Myocardial Viability and Prognosis in Takotsubo Cardiomyopathy (Traisient Left Ventricular Apical Ballooning Syndrome) Am J Cardiol 2007;100(2), 296-301.
  25. Kohsaka S, Goto M, Virani S, Lee, VV, Aoki N, Elayda M, Reul, R., Wilson JM. Long-Term Clinical Outcome of Coronary Artery Stenting or Coronary Artery Bypass Grafting in Patients with Multiple Vessel Disease. J of Thoracic and CV Surg 2008 Aug;136(2):500-6.
  26. Frank CM, Palanichamy N, Kar B, Wilson JM, Gregoric ID, Loyalka P, Civitello AB. Use of a Percutaneous Ventricular Assist Device for Treatment of Cardiogenic Shock due to Critical Aortic Stenosis. Tex Heart Inst J. 2006;33(4):487-9.
  27. Ferguson JJ, Wilson JM, Diez J. Antithrombotic therapy and the transition to the catheterization laboratory in UA/NSTEMI. Minerva Cardioangiol. 2007;55:529-56.
  28. Lubanda JCM, Palacek T, Trckova R, Wilson JM, Linhart A. Preload Dependence of the Time Interval between Onset of Mitral Inflow and Early Diastolic Mitral Annular Velocity: A Study in Healthy Subjects. Echocardiography: A Jrnl. Of CV Ultracound & Allied Tech. 2008;25(3):249-254.
  29. Goto M, Kohsaka S, Aoki N, Lee VV, Elayda MA, Wilson JM. Risk Stratification after successful coronary revascularization. Cardiovasc Revasc Med 9(2008)132-139.
  30. Madan P, Elayda MA, Lee VV, Wilson JM. Predicting major adverse cardiac events after percutaneous coronary intervention: the Texas Heart Institute risk score. Am Heart J 2008;155(6):1068-74.
  31. Virani SS, Nambi V, Lee VV, Elayda M, Reul R, Wilson JM, Ballantyne CM. Does Preoperative Statin Therapy Improve Outcomes in Patients undergoing Isolated Cardiac Valve Surgery? Am J Cardiol 2008;102:1235-1239.
  32. Nazeri A, Massumi A, Rasekh A, Saeed M, Frank C, Wilson JM, Lopez JA, Razavi M. Cardiac resynchronization therapy may improve symptoms of congestive heart falure in patients without electrical or mechanical dyssynchrony. Eurospace. 2009;11(1):86-8.
  33. Virani SS, Nambi V, Razavi M, Lee VV, Elayda M, Wilson JM, Ballantyne CM. Preoperative statin therapy is not associated with a decreased incidence of postoperative atrial fibrillation in patients undergoing cardiac surgery. Am Heart J 2008;155(3):541-6.
  34. Wilson JM. Diagnosis and treatment of acquired coronary artery disease in adults. Postgrad Med J. 2009 Jul;85(1005):364-5. Review
  35. Kohsaka S, Goto M, Virani S, Lee VV, Aoki N, Elayda MA, Reul RM, Wilson JM. Long-term clinical outcome of coronary artery stenting or coronary artery bypass grafting in patients with multiple-vessel disease. J Thorac Cardiovasc Surg. 2008 Aug;136(2):500-6.
  36. Sanon S, Lee VV, Elayda M, Wilson J. Use of Aspirin Versus Clopidogrel Plus Aspirin After Coronary Artery Bypass Graft Surgery. Clin Appl Thromb Hemost. 2008 Dec 15. [Epub ahead of print] 2009;15(5):540-544
  37. Nazeri A, Massumi A, Wilson JM, Frank CM, Bensler M, Cheng J, Saeed M, Rasekh A, Razavi M. Arrhythmogenicity of weight-loss supplements marketed on the internet. Heart Rhythm. 2009 May;6(5):658-62. Epub 2009 Feb 14.
  38. Weisberg AD, Weisberg EL, Wilson JM, Collard CD. Preoperative Evaluation and Preparation of the Patient for Cardiac Surgery. Medical Clinics of North Vol 93 (5), 2009.
  39. Cheong BY, Muthupillai R, Wilson JM, Sung A, Huber S, Amin S, Elayda MA, Lee VV, Flamm SD. Prognostic significance of delayed-enhanced magnetic resonance imaging: survival of 857 patients with and without left ventricular dysfunction. Circulation. 2009 Nov 24;120(21):2069-76. Epub 2009 Nov 9.
  40. Madan P, Elayda MA, Lee VV, Wilson JM. Risk-prediction models for mortality after coronary artery bypass surgery: Application to individual patients. Int J Cardiol. 2010 Mar 2. [Epub ahead of print]
  41. Díez JG, Wilson JM. Practical strategies for the management of anticoagulation therapy: unsolved issues in the cardiac catheterization laboratory. Cardiovasc Drugs Ther. 2010 Apr;24(2):161-74. Review.
  42. Wilson JM. When relativity has no relevance. Tex Heart Inst J. 2010;37(2):159-60.
  43. Attallah A, Cheong BY, Bernicker E, Wilson JM. Cardiac chloroma: novel presentation and subsequent diagnosis with cardiac magnetic resonance imaging. Tex Heart Inst J. 2010;37(2):242-3.
  44. Kohsaka S, Kimura T, Goto M, Lee VV, Elayda M, Furukawa Y, Fukushima M, Komeda M, Sakata R, Willerson JT, Wilson JM, Kita T. Difference in patient profiles and outcomes in Japanese versus American patients undergoing coronary revascularization (collaborative study by CREDO-Kyoto and the Texas Heart Institute Research Database). Am J Cardiol. 2010 Jun 15;105(12):1698-704.
  45. Nazeri A, Razavi M, Elayda MA, Lee VV, Massumi A, Wilson JM. Race/Ethnicity and the incidence of new-onset atrial fibrillation after isolated coronary artery bypass surgery. Heart Rhythm. 2010 Oct;7(10):1458-63.
  46. Sanon, S., Lee V. V., Elayda, M., Wilson, JM. Use of Clopidogrel plus Aspirin versus Aspirin Post-Coronary Artery Bypass Grafting. Clin Appl Thromb Hemost 2009:15:540-544.
  47. May S, Wilson JM. The Comparative efficacy of Percutaneous and Surgical Coronary Revascularization in 2009: A Review. Tex Heart Inst J. 2009;36(5):375-86.
  48. Guha, A., Wilson JM. The Impact of Renal Insufficiency Upon Outcomes After Coronary Revascularization. Tex Heart Inst J (in press)
  49. Virani S, Nambi V, Lee VV, Elayda M, Pan W, Peterson L, Wilson JM, Willerson JT, Ballantyne CM. Obesity: an independent predictor of in-hospital post operative renal insufficiency among patients undergoing cardiac surgery? Tex Heart Inst J 2009;36(6):540-5.
  50. Alam M, Virani SS, Simpson L, Williams SB, Wilson JM. Cardiac sarcoidosis: A clinical entity uncommonly recognized. Tex Heart Inst J. 2009;36(5):501-3.
  51. Weisberg AD, Weisberg EL, Wilson JM, Collard CD. Preoperative Evaluation and Preparation of the Patient for Cardiac Surgery. Anesthesiology Clin 27(2009)633-648.
  52. Ashrith G, Elayda M, Wilson JM. Revascularization Options in Patients with Chronic Kidney Disease. Tex Heart Inst J 2010;37(1):9-18.
  53. Ahmed A, Gondi S, Cox C, Wang S, Stupin IV, Shankar KJ, Munir SM, Sobash E, Brewer A, Ferguson JJ, Elayda MA, Casscells SW, Wilson JM., Circadian Body Temperature Variability is an Indicator of Poor Prognosis in Cardiomyopathic Hamsters J Card Fail. 2010 Mar; 16(3):268-74
  54. Virani SS, Nambi V, Polsani V, Lee VV, Elayda M, Kohsaka S, Pan W, Reul R, Wilson JM, Petersen L, Willerson JT, Ballantyne. Preoperative Statin Therapy Decreases Risk of Postoperative Renal Insufficiency. Cardiovas Ther 2010;28:80-86.
  55. Wilson JM. STEMI Limbo: Chasing a hard Target. Tex Heart Inst J 2010;37(3):312-315.
  56. Wilson JM. Unintended Consequences: Avoiding Resentosis and Stent Thrombosis. (Editorial Commentary) Tex Heart Inst J 2010;37(3):341-342.
  57. Wilson JM. Race/Ethnicity and the Incidence of New-Onset Atrial Fibrillation After Isolated Coronary Artery Bypass Surgery. Heart Rhythm J (in press)
  58. Wilson JM, Birnbaum Introducing a New Algorithm in Inferior ST-Segment Elevation Myocardial Infarction to Predict the Culprit Artery and Distinguish Proximal Versus Distal Lesions.. Coronary Artery Disease (in press)
  59. Huang HD, Tran V, Jneid H, , Wilson JM, Birnbaum Y. Comparison of Angiographic Findings in Patients With Acute Anteroseptal Versus Anterior Wall ST-Elevation Myocardial Infarction. Am J Cardiol. 2011 Mar 15;107(6):827-32. Epub 2011 Jan 19.
  60. Ashrith G, Lee VV, Elayda MA, Reul RA, Wilson JM. Short- and Long-Term Outcomes of Coronary Artery Bypass Grafting or Drug-Eluting Stent Implantation for Multivessel Coronary Artery Disease in Patients With Chronic Kidney Disease. American Journal of Cardiology 2010;106(3): 348-353.
  61. Virani SS, Brautbar A, Lee VV, Elayda M, Sami S, Nambi V Frazier L, Wilson JM, Willerson JT, Boerwinkle E, Ballantyne CM. Usefulness of Single Nucleotide Polymorphism in Chromosome 4q25 to Predict In-Hospital and Long Term Development of Atrial Fibrillation and Survival in Patients Undergoing Coronary Artery Bypass Grafting. Am J Cardiol. 2011 May 15;107(10):1504-9.
  62. Alam M, Siddiqui S, Lee VV, Elayda MA, Nambi V, Yang EY, Jneid HM, Wilson JM, Ballantyne CM, Virani SS. Isolated Coronary Artery Bypass Grafting in Obese Individuals. Circ J. 2011 May 25;75(6):1378-85.
  63. Hira RS, Wilson JM, Birnbaum Y. Introducing a new algorithm in inferior ST-segment elevation myocardial infarction to predict the culprit artery and distinguish proximal versus distal lesions. Coron Artery Dis. 2011 May;22(3):165-70.
  64. Tran V, Huang HD, Diez JG, Kalife G, Goswami R, Paniagua D, Jneid H, Wilson JM, Sherron SR, Birnbaum Y. Differentiating ST-Elevation Myocardial Infarction from Nonischemic ST-Elevation in Patients With Chest Pain. Am J Cardiol. 2011 Jul 24. [Epub ahead of print]
  65. Birnbaum Y, Wilson JM, Nikus K. Appropriate cardiac catheterization laboratory activation: Optimizing electrocardiogram interpretation and clinical decision making for acute ST-elevation myocardial infarction. Am Heart J. 2011 Jul;162(1):e3
  66. Ahmed A, Gondi S, Cox C, Zheng M, Mohammed A, Stupin I, Wang S, Vela D, Brewer A, Elayda M, Buja LM, Casscells SW, Wilson JM. Body Temperature Circadian Rhythm Variability Corresponds to Left Ventricular Systolic Dysfunction in Decompensated Cardiomyopathic Hamsters. J Card Fail. 2011 Nov;17(11):937-43.
  67. Tran V, Huang HD, Diez JG, Kalife G, Goswami R, Paniagua D, Jneid H, Wilson JM, Sherron SR, Birnbaum Y. Differentiating ST-Elevation Myocardial Infarction from Nonischemic ST-Elevation in Patients With Chest Pain. Am J Cardiol. 2011 Jul 24. [Epub ahead of print]
  68. Munir M, Aliota J, Ahmed A, Mohammed A, Lee VV, Elayda M, Wilson JM,. Sirolimus-eluting stents versus bare-metal stents in routine clinical use: a nonrandomized comparison. Tx Heart Inst J. 2011;38(5):508-15.
  69. Goto M, Kohsaka S, Lee VV, Elayda MA, Aoki N, Wilson JM. Risk stratification of coronary revascularization patients by using clinical and angiographic data. J Cardiovasc Surg (Torino). 2011 Dec;52(6):863-71.
  70. Alam M, Lee VV, Elayda MA, Shahzad SA, Yang EY, Nambi V, Jneid H, Pan W, Coulter S, Wilson JM, Ramanathan KB, Ballantyne CM, Virani SS. Association of gender with morbidity and mortality after isolated coronary artery bypass grafting. A propensity score matched analysis. Int J Cardiol. 2012 Jan 10. [Epub ahead of print]
  71. Kohsaka S, Goto M, Nagai T, Lee VV, Elayda M, Furukawa Y, Fukushima M, Komeda M, Sakata R, Ohsugi M, Fukuda K, Wilson JM, Kita T, Kimura T. Impact of diabetes among revascularized patients in Japan and the u.s. Diabetes Care. 2012 Mar;35(3):654-9.
  72. Virani SS, Brautbar A, Lee VV, Elayda M, Morrison AC, Grove ML, Nambi V, Frazier L, Wilson JM, Willerson JT, Boerwinkle E, Ballantyne CM. Chromosome 9p21 Single Nucleotide Polymorphisms Are Not Associated With Recurrent Myocardial Infarction in Patients With Established Coronary Artery Disease. Circ J. 2012;76(4):950-6.
  73. Mehta N, Huang HD, Bandeali S, Wilson JM, Birnbaum Y. Prevalence of acute myocardial infarction in patients with presumably new left bundle-branch block. J Electrocardiol. 2012 45(4):361-7.
  74. Kayani WT, Huang HD, Bandeali S, Wilson JM, Virani S, Birnbaum Y. ST elevation: Telling pathology from the benign patterns. Glob J Health Sci 2012; 4:51-63.
  75. Satya K, Kalife G, Navarijo J, Rasekh A, Wilson JM. Transseptal Biopsy of a Left Atrial Mass with Three-Dimensional Transesophageal Echocardiographic Guidance. Tex Heart Inst J 2012;39(5):707-10..
  76. Fernandes, MR, Fish RD, Canales J, Aliota J, Silva GV, Perin EC, Elayda MA, Wilson JM. Restoration of Microcirculatory Patency after Myocardial Infarction. Tx Heart Inst J 2012;39(3):342-50.
  77. Bandeali SJ, Kayani WT, Lee VV, Pan W, Elayda MA, Nambi V, Jneid HM, Alam M, Wilson JM, Birnbaum Y, Ballantyne CM, Virani SS. Outcomes of Preoperative Angiotensin-Converting Enzyme Inhibitor Therapy in Patients Undergoing Isolated Coronary Artery Bypass Grafting. Am J Cardio 2012 Oct 1;110(7):919-23.
  78. Ganjehei L, Wilson JM. Anticoagulants for Stroke Prevention in Nonvalvular Atrial Fibrillation. Tex Heart Inst J 2012;39(4):517-525.
  79. Cevik C, Shah N, Wilson JM, Stainback RF. Multiple Left Ventricular Thrombi in a patient with Left Ventricular Noncompaction (Case Report). Tex Heart Inst J 2012:39(4):550-3.
  80. Kayani WT, Bandeali SJ, Lee VV, Pan W, Elayda MA, Khan A, Nambi V, Jneid HM, Alam M, Wilson JM, Huang HD, Birnbaum Y, Ballantyne CM, Virani SS. Association between statins and infections after coronary artery bypass grafting. Int J Cardiol. 2012 Oct 6
  81. Ganjehei L, Massumi A, Razavi M, Wilson JM. Orthostatic hypostension as a manifestation of vitamin b(12) deficiency. Tex Heart Inst J. 2012;39(5):722-3.
  82. Diffuse ST Depression with ST Elevation in aVR: Is this Pattern Specific for Global Ischemia Due to Left Main coronary Artery Disease? In Press J of Electrocardiology.
  83. Bandeali S, Wilson JM. Association Between Preoperative Diuretic Use and In-hospital Outcomes After Cardiac Surgery. Accepted for publication in Cardiovascular Therapeutics.
  84. Sanon S, Lee VV, Elayda MA, Gondi S, Livesay JJ, Reul GJ, Wilson JM. Predicting Early Death after Cardiovascular Surgery. Tex Heart Inst J 2013:40(2):156-62.
  85. Bandeali SJ, Kayani WT, Lee VV, Elayda M, Alam M, Huang HD, Wilson JM, Jneid H, Birnbaum Y, Deswal A, Farmer J, Ballantyne CM, Virani SS. Association Between Preoperative Diuretic Use and In-hospital Outcomes After Cardiac Surgery. Cardiovasc Ther. 2013 Mar 20. doi: 10.1111/1755-5922.12024.
  86. Alsaab A, Hira RS, Alam M, Elayda M, Wilson JM, Birnbaum Y. Usefulness of T wave inversion in leads with ST elevation on the presenting electrocardiogram to predict spontaneous reperfusion in patients with anterior ST elevation acute myocardial infarction.Am J Cardiol. 2014
  87. Moore C, Addison D, Wilson JM, Zeluff B. First case of Fusobacterium necrophorum endocarditis to have presented after the 2nd decade of life.Tex Heart Inst J. 2013;40(4):449-52.
  88. Nascimbene A, Joggerst S, Reddy KJ, Cervera RD, Ott DA, Wilson JM, Stainback RF. Aortic valve regurgitation that resolved after a ruptured coronary sinus aneurysm was patched. Tex Heart Inst J. 2013;40(4):489-92.
  89. Hojjati MR, Muthupillai R, Wilson JM, Preventza OA, Cheong BY. Assessment of perfusion and wall-motion abnormalities and transient ischemic dilation in regadenoson stress cardiac magnetic resonance perfusion imaging.Int J Cardiovasc Imaging. 2014 Jun;30(5):949-57.
  90. Virani SS, Lee VV, Brautbar A, Grove ML, Nambi V, Alam M, Elayda M, Wilson JM, Willerson JT, Boerwinkle E, Ballantyne CM. Single nucleotide polymorphisms in cholesteryl ester transfer protein gene and recurrent coronary heart disease or mortality in patients with established atherosclerosis. Am J Cardiol. 2013 Nov 1;112(9):1287-92.
  91. Wei EY, Hira RS, Huang HD, Wilson JM, Elayda MA, Sherron SR, Birnbaum Y. Pitfalls in diagnosing ST elevation among patients with acute myocardial infarction. J Electrocardiol. 2013 Nov-Dec;46(6):653-9.
  92. Virani SS, Lee VV, Brautbar A, Grove ML, Nambi V, Alam M, Elayda M, Wilson JM, Willerson JT, Boerwinkle E, Ballantyne CM. Single nucleotide polymorphisms in cholesteryl ester transfer protein gene and recurrent coronary heart disease or mortality in patients with established atherosclerosis. Am J Cardiol. 2013 Nov 1;112(9):1287-92.
  93. Moore C, Addison D, Wilson JM, Zeluff B. First case of Fusobacterium necrophorum endocarditis to have presented after the 2nd decade of life. Tex Heart Inst J. 2013;40(4):449-52. Review.
  94. Nascimbene A, Joggerst S, Reddy KJ, Cervera RD, Ott DA, Wilson JM, Stainback RF. Aortic valve regurgitation that resolved after a ruptured coronary sinus aneurysm was patched. Tex Heart Inst J. 2013;40(4):489-92.
  95. Alsaab A, Hira RS, Alam M, Elayda M, Wilson JM, Birnbaum Y. Usefulness of T wave inversion in leads with ST elevation on the presenting electrocardiogram to predict spontaneous reperfusion in patients with anterior ST elevation acute myocardial infarction. Am J Cardiol. 2014 Jan 15;113(2):270-4.
  96. Hojjati MR, Muthupillai R, Wilson JM, Preventza OA, Cheong BY. Assessment of perfusion and wall-motion abnormalities and transient ischemic dilation in regadenoson stress cardiac magnetic resonance perfusion imaging. Int J Cardiovasc Imaging. 2014 Jun;30(5):949-57.
  97. Hira RS, Moore C, Huang HD, Wilson JM, Birnbaum Y. T wave inversions in leads with ST elevations in patients with acute anterior ST elevation myocardial infarction is associated with patency of the infarct related artery. J Electrocardiol. 2014 Jul-Aug;47(4):472-7.
  98. Bandeali SJ, Gosch K, Alam M, Kayani WT, Jneid H, Fiocchi F, Wilson JM, Chan PS, Deswal A, Maddox TM, Virani SS. Coronary Artery Disease Performance Measures and Statin Use in Patients With Recent Percutaneous Coronary Intervention or Recent Coronary Artery Bypass Grafting (from the NCDR PINNACLE Registry). Am J Cardiol. 2015 Apr 15;115(8):1013-8.
  99. Inohara T, Kohsaka S, Goto M, Furukawa Y, Fukushima M, Sakata R, Elayda M, Wilson JM, Kimura T. Hypothesis of Long-Term Outcome after Coronary Revascularization in Japanese Patients Compared to Multiethnic Groups in the US. PLoS One 2015; 10(5): e0128252
  100. Wilson JM, Muthupillai R, Cheong B. Characterization of Hypertrophic Cardiomyopathy Using Magnetic Resonance “Fibrosis” Imaging. Ann Cardiovasc Dis. 2016;1(2):1008

Book Chapters

  1. Ferguson JJ, Wilson JM: Coronary Artery Bypass Surgery and Percutaneous Transluminal Coronary Angioplasty. In Willerson JT, Cohn JN: Cardiovascular Medicine, Churchill Livingstone, New York 1995:670-701.
  2. Wilson JM: Anticoagulant Monitoring. In: Becker R, Textbook of Coronary Thrombosis and Thrombolysis. Kluwer Academic Publishers 1997.
  3. Ferguson JJ, Wilson JM. Anticoagulation Monitoring for Percutaneous Transluminal Coronary Angioplasty. In: Becker R, Textbook of Coronary Thrombosis and Thrombolysis. Kluwer Academic Publishers 1997.
  4. Wilson JM, Hall RJ, Ferguson JJ: Coronary Artery Bypass Surgery and Percutaneous Transluminal Coronary Angioplasty. In Willerson JT, Cohn JN: Cardiovascular Medicine, Churchill Livingstone, New York 2000:670-701.
  5. Wilson JM, Kim P, Ferguson JJ. Antiplatelet Drugs. In: Pifarre R SB, ed. Evidence Based Management of the Acute Coronary Syndrome. (Book Chapter) Philadelphia, PA: Hanley & Belfus, Inc., 2000.
  6. Strickman N, Wilson JM: Peripheral vascular disease. In: Cardiovascular Disease in Women. Eds: Wilansky SW, Willerson JT. 2001.
  7. Gupta K, Wilson JM, Ferguson JJ: Anticoagulation Monitoring. Textbook of Clinical Interventional and Investigational Thrombocardiology. Ed: Becker RC. 2005.
  8. Gupta K, Wilson JM, Ferguson JJ: Anticoagulation in Venous Thromboembolic Diseases. Textbook of Clinical Interventional and Investigational Thrombocardiology . Ed. Becker RC. 2005.
  9. Gupta K, Wilson JM, Ferguson JJ: Chronic Oral Anticoagulation Therapy in Cardiac Disease. Textbook of Clinical Interventional and Investigational Thrombocardiology. Ed: Becker RC. 2005.
  10. Strickman N, Wilson JM: Peripheral vascular disease. In: Cardiovascular Disease in Women. Eds: Wilansky SW, Willerson JT. 2007.
  11. Willerson, J.T., Wilson, JM. Myocardial Revascularization with Cardiologic Interventional Devices.In: Cohn LH, Edmunds LH Jr, eds. Cardiac Surgery in the Adult. New York: McGraw-Hill, 2007.
  12. Wilson JM, Ferguson JJ, Hall RJ. Coronary Artery Bypass Surgery and Percutaneous Coronary Revascularization: Impact on Morbidity and Mortality in Patients with Coronary Artery Disease. Cardiovascular Medicine, Third Edition Ed. Willerson, Cohn, Wellens, Holmes. 2007
  13. Wilson JM, Willerson JT. Myocardial Revascularization with Percutaneous Devices.
  14. Díez JG, Wilson JM. Ventriculography / Aortography. In: Cardiac Catheterization, Coronary and Peripheral Angiography, and Interventional Procedures. 1st Ed. Editors: Debabrata Mukherjee, Eric R. Bates, Marco Roffi, and David J. Moliterno. Informa Healthcare 2009.
  15. Wilson JM, Willerson JT. Myocardial revascularization with percutaneous devices. In: Cohn L, ed. Cardiac surgery in the adult. New York: McGraw Hill Professional; 2012:461-478.
  16. Wilson JM. Coronary Artery Bypass Surgery and Percutaneous Coronary Revascularization: Impact on Morbidity and Mortality in Patients with Coronary Artery Disease. Coronary Artery Disease Ed: Willerson JT, Holmes Jr DR. 2015.
  17. Birnbaum U, Wilson JM, Nikus K. The Electrocardiogram in Coronary Artery Disease. Coronary Artery Disease Ed: Willerson JT, Holmes Jr DR. 2015.
  18. Wilson JM, Willerson JT. Myocardial revascularization with percutaneous devices. In: Cohn L, ed. Cardiac surgery in the adult. New York: McGraw Hill Professional; 2017:461-478.
  19. Díez JG, Wilson JM. Ventriculography / Aortography. In: Cardiac Catheterization, Coronary and Peripheral Angiography, and Interventional Procedures. 1st Ed. Editors: Debabrata Mukherjee, Eric R. Bates, Marco Roffi, and David J. Moliterno. Informa Healthcare 2017.

Editorial/Non-peer Review

  1. Wilson JM, George WG, et al. "Toxicity of Dioxins", Open File No. 20. Environmental Institute for Waste Management Studies ‑ Publications, University of Alabama 191pp. 1988
  2. Wilson JM, Walton B. Lesions and lipids and radicals--O my! : Tex Heart Inst J. 2004;31(2):118-26.
  3. Wilson, JM. A Day Without Orange Juice is Like an Invitation to Atrial Fibrillation Tex Heart Inst J 2007;34:265-7.

Television

  • “Hitler the Junkie”. National Geographic Documentary participation: Interpretation of Hitler’s ECG’s. http://channel.nationalgeographic.com/galleries/hitler-the-junkie/at/hitlers-helpers-2090722/

Lectures- International

  • Thailand Cardiovascular Society Scientific Meeting, Bangkok, Thailand March 1998.
  • Mediterranean Cardiovascular Society Scientific Meeting. Rhodes, Greece June 2002
  • 9th International Symposium on Thromboembolism. London, U.K. June 2003
  • DeltaCardio meeting of the Egyptian Cardiac Society, Alexandria, Egypt 2004
  • Kuwait Cardiac Society, Kuwait City, 2005

Service/Community

American Heart Association-

  • Physician’s Volunteer Advisory Board 1999
  • Board of Directors, Houston Division 2003

Established the “St. Luke’s/Episcopal Charities Cardiovascular Clinic” an indigent clinic for the diagnosis and treatment of adult congenital and complex cardiovascular disease- Physician director. 1997-2000

< Back to Cardiology

Schedule an appointment.

Our friendly office staff will be happy to help you schedule an appointment. Call (713)790-1775 or (832)336-1530.

Office Hours

Monday - Friday:
8:30 AM - 5:00 PM
Saturday - Sunday:
Closed

Our office address

6560 Fannin
Scurlock Tower Suite 1630
Houston, TX 77030

Driving/Parking Instructions

Scurlock Tower Parking is accessed from Fannin Street

Self Park:
0-20 minutes: free
21 minutes – 3 hours: $7
3-4 hours: $9
4-5 hours: $11
5-24 hours: $13
Lost ticket: $13

VALET PARKING is available using the access from Fannin Street
5:30 a.m. - 7 p.m., Monday – Friday (closed weekends and holidays)

0-3 hours: $10
3-24 hours: $15
Each additional day: $15

Link for additional parking information:
https://www.houstonmethodist.org/locations/texas-medical-center/for-patients/parking/

Scurlock is easily accessible via the Metro Rail Red Line.